stella
beta
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma — Stella
Recruiting
Back to Melanoma Stage III trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Moffitt Cancer Center, Tampa, Florida
View full record on ClinicalTrials.gov